Certainty right from the start
Join the Certara community of leading experts and scientists in biosimulation, clinical pharmacology, regulatory science, AI/ML, and clinical data science as we explore what’s possible at the Certainty US Annual Conference. Together, we’ll exchange insights, best practices, and proven strategies to bring greater clarity and confidence to every stage of drug discovery and development.
Certainty EMEA will offer the same dynamic, multi-format program that made our 2024 events so successful.
An emphasis on Model Informed Drug Development, from its roots in mechanistic modeling and biosimulation to applications in target product profiling and pipeline planning
Plenary sessions on how AI, regulatory changes, and business realities will affect every stage of development from market to molecule.
See what awaits you at Certainty
Certainty EMEA 2026 will showcase how you can reduce risk and achieve success from molecule to market, with certainty right from the start.
Based on attendee feedback, Certainty 2026 will feature more in-depth UGMs and Workshops on Pinnacle 21, QSP, Phoenix, Discovery, PK/PD, and PBPK. Choose the interactive sessions that best suit your interests over the 2-days:
P21 Live: Digital Data Flow Optimization
Â
Follow the flow of data from protocol all the way to submission in this track focused on the Pinnacle 21 technology. We’ll look more closely at P21 capabilities, from mapping specs and APIs to the progress of our solution for metadata management.
Phoenix User Meeting
Â
Phoenix users can explore how empirical PK/PD methods work alongside in silico approaches by attending Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, you’ll get an interactive look at new features, our roadmap, and AI’s expanding role in modeling and reporting.
QSP Summit
Â
Attendees of the QSP Summit are also encouraged to attend Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, we will explore how QSP is transforming MIDD through computational modeling, AI integration, and mechanistic insights. Sessions will feature case studies across disease areas, and forward-looking discussions on regulatory adoption and the future of predictive modeling.
Discovery: Intelligent Lead Optimization with Chemaxon and D360
Â
With the explosion of new modalities, informatics is expanding its scope as AI closes gaps between chemistry, safety, and efficacy. Join this track to explore how predictive modeling is reshaping compound design and enabling a clearer view downstream in drug discovery.
PBPK Modeling Workshop
Â
Attendees of PBPK Modeling Workshop are also encouraged to attend Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, we’ll showcase how PBPK informs decisions for first-in-human dosing to formulation, drug–drug interactions, and special population optimization. Expert talks and case studies will offer practical insights to strengthen confidence in model-informed development.
Modeling and Simulation from Strategy to Approval
Â
Learn how empirical PK/PD methods like NCA and popPK are complementing in silico approaches like PBPK and QSP to answer the most daunting challenges in development, from optimal first-in-human dosing to presenting clin pharm evidence effectively in your NDA or BLA. Attendees of the Phoenix User Meeting, QSP Summit, and PBPK Modeling Workshop are encouraged to attend this session on Day 1 of Certainty.
Meet Our Sponsor
Reserve Your Spot
This two-day event will be filled with exciting customer presentations, industry thought leaders, valuable training sessions, and big announcements from Certara about the future of our products and services.Â
Radisson Grand PlaceÂ
Brussels, Belgium
You can book your stay with Radisson Collection Hotel, Grand Place Brussels.